Trial Profile
Comparison of pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2011
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Pharmacokinetics
- 04 Jun 2007 Results have been reported.
- 12 Aug 2006 New trial record.